New Haven, CT, United States of America

Scott B Dewell

This inventor holds 4 USPTO granted patents and 1 EPO patent. Top assignee: 454 Life Sciences Corporation. Active years: 2007-2008.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Scott B Dewell. Retrieved from https://idiyas.com/inventor/scott-b-dewell

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile



Average Co-Inventor Count = 7.2

ph-index = 4

Forward Citations = 2,072(Granted Patents)


Company Filing History:


Years Active: 2007-2008

Loading Chart...
Loading Chart...
4 patents (USPTO):Explore Patents

Title: Scott B. Dewell: Innovating Nucleic Acid Sequencing

Introduction: Scott B. Dewell, an accomplished inventor based in New Haven, CT, has made significant contributions to the field of molecular biology. With a total of four patents to his name, his work primarily focuses on innovative methods for nucleic acid sequencing. His inventions pave the way for highly efficient sequencing processes, facilitating advancements in genetic research and biotechnology.

Latest Patents: Among his notable patents, Scott B. Dewell has developed two key inventions: "Apparatus and method for sequencing a nucleic acid" and "Method of sequencing a nucleic acid." Both patents disclose methods and apparatuses that enable the arraying of numerous independent sequencing reactions in parallel, allowing for the simultaneous sequencing of over 10,000 different oligonucleotides. This groundbreaking approach significantly enhances the efficiency and scalability of nucleic acid sequencing.

Career Highlights: Currently, Scott is associated with 454 Life Sciences Corporation, a leader in the field of DNA sequencing technologies. His role in the company allows him to apply his innovative ideas and contribute to the ongoing evolution of biotechnological methods.

Collaborations: Throughout his career, Scott has worked closely with notable colleagues, including Joel S. Bader. Their collaborative efforts likely contribute to the advancement of sequencing technologies and the development of new methods that could further enhance genetic research capabilities.

Conclusion: Scott B. Dewell stands out as a prominent inventor with a dedicated focus on nucleic acid sequencing innovation. His patents represent significant advancements that promise to revolutionize the field of molecular biology, making genetic research more efficient and accessible for the scientific community. As technology continues to evolve, it is inventors like Scott who lead the charge towards new frontiers in biotechnology.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…